Manufacturers Life Insurance Company, The Kinnate Biopharma Inc. Transaction History

Manufacturers Life Insurance Company, The

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$2.33 - $6.84 $28,104 - $82,504	-12,062 Closed	0 $0
Q4 2022 Aug 11, 2023	BUY	$5.26 - $12.19 $883 - $2,047	168 Added 1.41%	12,062 $73,000
Q4 2022 Feb 13, 2023	BUY	$5.26 - $12.19 $883 - $2,047	168 Added 1.41%	12,062 $73,000
Q3 2022 Aug 11, 2023	SELL	$9.86 - $15.76 $3,549 - $5,673	-360 Reduced 2.94%	11,894 $142,000
Q3 2022 Nov 03, 2022	SELL	$9.86 - $15.76 $3,549 - $5,673	-360 Reduced 2.94%	11,894 $142,000
Q2 2022 Aug 11, 2023	BUY	$7.43 - $13.0 $1,456 - $2,548	196 Added 1.63%	12,254 $154,000
Q2 2022 Aug 15, 2022	BUY	$7.43 - $13.0 $1,456 - $2,548	196 Added 1.63%	12,254 $155,000
Q1 2022 Aug 11, 2023	SELL	$7.73 - $17.99 $30 - $71	-4 Reduced 0.03%	12,058 $135,000
Q1 2022 May 20, 2022	SELL	$7.73 - $17.99 $19,912 - $46,342	-2,576 Reduced 17.6%	12,058 $136,000
Q4 2021 Feb 16, 2022	BUY	$16.5 - $25.48 $13,678 - $21,122	829 Added 6.01%	14,634 $259,000
Q3 2021 Nov 12, 2021	BUY	$17.81 - $24.87 $245,867 - $343,330	13,805 New	13,805 $318,000
Q2 2021 Aug 12, 2021	SELL	$22.19 - $31.55 $167,889 - $238,707	-7,566 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$26.99 - $40.0 $204,206 - $302,640	7,566 New	7,566 $236,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.